Diallyl sulfide as a potential dietary agent to reduce TNF-α- and histamine-induced proinflammatory responses in A7r5 cells

Molecular Nutrition and Food Research

Volumn 58, Issue 5, 2014, Pages 1069-1078

  Ho, Cheng Ying ^a   Weng, Chia Jui ^b   Jhang, Jhih Jia ^a   Cheng, Yu Ting ^a   Huang, Shang Ming ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Diallyl sulfide; Histamine; Inflammation; Nrf2; TNF

Indexed keywords

ALLYL COMPOUND; ALLYL SULFIDE; ANTIOXIDANT; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NFE2L2 PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; SULFIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; DRUG EFFECTS; GARLIC; GENETICS; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ALLYL COMPOUNDS; ANIMALS; ANTIOXIDANTS; CELL LINE; GARLIC; HISTAMINE; INFLAMMATION; INTERLEUKIN-1BETA; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHYTOCHEMICALS; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SULFIDES; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899026137     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300617     Document Type: Article

References (39)

1. Ho, W. E., Cheng, C., Peh, H. Y., Xu, F. et al., Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma. Free Radic. Biol. Med. 2012, 53, 498-507.
2. Medzhitov, R., Janeway, C. J., Innate immune recognition: mechanisms and pathways. Immunol. Rev. 2000, 173, 89-97.
3. Russo, C., Polosa, R., TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin. Sci. 2005, 109, 135-142.
4. Thomas, P. S., Yates, D. H., Barnes, P. J., Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Crit. Care Med. 1995, 152, 76-80.
5. Thomas, P. S., Heywood, G., Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax. 2002, 57, 774-778.
6. Brightling, C., Berry, M., Amrani, Y., Targeting TNF-alpha: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 2008, 121, 5-10.
7. O'Mahony, L., Akdis, M., Akdis, C. A., Regulation of the immune response and inflammation by histamine and histamine receptors. J. Allergy Clin. Immunol. 2011, 128, 1153-1162.
8. Hirota, N., Risse, P.A., Novali, M., McGovern, T. et al., Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. FASEB J. 2012, 26, 1704-1716.
9. Hamid, Q., Tulic, M., Immunobiology of asthma. Annu. Rev. Physiol. 2009, 71, 489-507.
10. Akdis, C. A., Jutel, M., Akdis, M., Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem. Immunol. Allergy 2008, 94, 67-82.
11. Seike, M., Takata, T., Ikeda, M., Kodama, H. et al., Histamine helps development of eczematous lesions in experimental contact dermatitis in mice. Arch. Dermatol. Res. 2005, 297, 68-74.
12. Tedeschi, A., Asero, R., Marzano, A. V., Lorini, M. et al., Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy 2009, 64, 1616-1622.
13. Rovensky, J., Imrich, R., Radikova, Z., Simorova, E. et al., Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis. Endocr. Regul. 2005, 39, 1-6.
14. Kalayarasan, S., Sriram, N., Sudhandiran, G., Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-κB, TNF-α and IL-1β. Life Sci. 2008, 82, 1142-1153.
15. Kip1 and mitogen-activated protein kinase. Mol. Nutr. Food Res. 2010, 54, 781-787.
16. Sriram, N., Kalayarasan, S., Ashokkumar, P., Sureshkumar, A. et al., Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of Caspase-3, NF-κB and ERK-2. Mol. Cell Biochem. 2008, 311, 157-165.
17. Shaik, I. H., George, J. M., Thekkumkara, T. J., Mehvar, R., Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model. Pharm. Res. 2008, 25, 2231-2242.
18. Ho, C. Y., Cheng, Y. T., Chau, C. F., Yen, G. C., Effect of diallyl sulfide on in vitro and in vivo Nrf2-mediated pulmonic antioxidant enzyme expression via activation ERK/p38 signaling pathway. J. Agric. Food Chem. 2012, 60, 100-107.
19. Qi, S., Xin, Y., Guo, Y., Diao, Y. et al., Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int. Immunopharmacol. 2012, 12, 278-287.
20. 2 via mechanisms involving AP-1 activation. Free Radic. Res. 2012, 46, 690-699.
21. Reddy, N. M., Vegiraju, S., Irving, A., Paun, B. C. et al., Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation. Am. J. Pathol. 2012, 180, 562-574.
22. Sugiura, H., Ichinose, M., Oxidative and nitrative stress in bronchial asthma. Antioxid. Redox. Signal. 2008, 104, 785-797.
23. Comhair, S. A., Erzurum, S. C., Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid. Redox. Signal. 2010, 12, 93-124.
24. Wajant, H., Death receptors. Essays Biochem. 2003, 39, 53-71.
25. Liu, Z. G., Molecular mechanism of TNF signaling and beyond. Cell Res. 2005, 15, 24-27.
26. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. et al., TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4, 387-396.
27. Devin, A., Cook, A., Lin, Y., Rodriguez, Y. et al., The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 2000, 12, 419-429.
28. Graziano, A. C., Cardile, V., Crascì, L., Caggia, S. et al., Protective effects of an extract from Citrus bergamia against inflammatory injury in interferon-gamma and histamine exposed human keratinocytes. Life Sci. 2012, 90, 968-974.
29. Granado-Serrano, A. B., Martín, M. A., Haegeman, G., Goya, L. et al., Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2 p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br. J. Nutr. 2010, 103, 168-179.
30. Holden, N. S., Gong, W., King, E. M., Kaur, M. et al., Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells. Br. J. Pharmacol. 2007, 152, 891-902.
31. Shimamoto, K., Hayashi, H., Taniai, E., Morita, R. et al., Antioxidant N-acetyl-l-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (I3C) in rats. J. Toxicol. Sci. 2011, 36, 775-786.
32. Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H. et al., Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 2005, 17, 22925-22936.
33. Kalayarasan, S., Prabhu, P. N., Sriram, N., Manikandan, R. et al., Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats. Eur. J. Pharmacol. 2009, 15, 162-171.
34. Giaime, E., Yamaguchi, H., Gautier, C. A., Kitada, T. et al., Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening. PLoS One 2012, 7, e40501.
35. Inden, M., Taira, T., Kitamura, Y., Yanagida, T. et al., PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis. 2006, 24, 144-158.
36. Yanagisawa, D., Kitamura, Y., Inden, M., Takata, K. et al., DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J. Cereb. Blood Flow Metab. 2008, 28, 563-578.
37. Aleyasin, H., Rousseaux, M. W., Phillips, M., Kim, R. H. et al., The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc. Natl. Acad. Sci. USA 2007, 20, 18748-18753.
38. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W. et al., DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 2006, 10, 15091-15096.
39. Sriram, N., Kalayarasan, S., Sudhandiran, G., Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm. Pharmacol. Ther. 2009, 223, 221-236.